Medicinal Products

Revlimid

Name Revlimid
Active Substance lenalidomide
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L04AX04
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 3
Kontrolni popis za zdravstvene radnike, verzija 2
Obrazac za prijavu trudnoće, verzija 2
Obrazac pristanka bolesnika, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnika, verzija 3
Kartica za bolesnika, verzija 2

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/revlimid

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novim važnim preporukama s obzirom na reaktivaciju virusa uz primjenu lenalidomida (Revlimid) 08.11.2016 Celgene Europe Limited
Back